Richard M. Cooper

University of Toronto

Papers

1

Total Citations

4

H-Index

1

About

Dr. Richard M. Cooper is a leading head and neck surgical oncologist whose research centers on optimizing treatment for oropharyngeal squamous cell carcinoma (OPSCC), particularly through transoral robotic surgery (TORS) and precision lymphatic mapping. His major contribution lies in challenging the standard practice of bilateral neck treatment for lateralized OPSCC. In his landmark 2022 study, Dr. Cooper demonstrated that using pre-operative SPECT-CT lymphatic mapping to guide contralateral neck management can safely avoid unnecessary irradiation in select patients, reducing treatment-related morbidity without compromising oncologic outcomes. This work, which has garnered early citations for its clinical significance, offers a paradigm shift toward more individualized, function-preserving care. Dr. Cooper’s research directly addresses the critical balance between cancer control and quality of life, making him a key figure in advancing minimally invasive surgical approaches. His findings are already shaping treatment guidelines and inspiring further investigation into de-escalation strategies for HPV-related OPSCC, positioning him as an innovator in the field of head and neck oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Evaluating contralateral neck failure in patients with lateralized OPSCC treated with transoral robotic surgery and neck management based on pre-operative SPECT-CT lymphatic mapping
4 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Toronto

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago